Prognostic nomogram for acute cerebral infarction based on risk factors: treatment with urinary kallidinogenase and edaravone-dexborneol
American Journal of Translational Research · 2026 · 18 (4) · 3015-3025
DOI: 10.62347/wbaf3073 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Translational Research, 2026. Verfasst von Fengqiao Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Dongyang People's Hospital, Wenzhou Medical University Dongyang 322100, Zhejiang, China. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Dongyang People's Hospital, Wenzhou Medical University Dongyang 322100, Zhejiang, China.
Zitieren
APA
Ma, F., Xu, D., Xu, Y., Wei, L., & Li, H. (2026). Prognostic nomogram for acute cerebral infarction based on risk factors: treatment with urinary kallidinogenase and edaravone-dexborneol. American Journal of Translational Research, 18(4), 3015-3025. https://doi.org/10.62347/wbaf3073
Vancouver
Ma F, Xu D, Xu Y, Wei L, Li H. Prognostic nomogram for acute cerebral infarction based on risk factors: treatment with urinary kallidinogenase and edaravone-dexborneol. American Journal of Translational Research. 2026;18(4):3015-3025. doi:10.62347/wbaf3073
BibTeX
@article{Ma2026,
author = {Ma, Fengqiao and Xu, Dongjuan and Xu, Yunyun and Wei, Lianyan and Li, Hongfei},
title = {Prognostic nomogram for acute cerebral infarction based on risk factors: treatment with urinary kallidinogenase and edaravone-dexborneol},
journal = {American Journal of Translational Research},
year = {2026},
volume = {18},
number = {4},
pages = {3015--3025},
doi = {10.62347/wbaf3073}
}
EUVIMED